SCHEMBL19310041

SCHEMBL19310041

BC1(B)c2c(N)cc(F)cc2C(=O)N1[C@]1(B)C(=O)NC(=O)C(B)(B)C1(B)B

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281401 0.81 — —
SCHEMBL21927072 0.80 AKR1B1 (0.32) —
SCHEMBL21925221 0.80 — —
SCHEMBL22199340 0.75 — —
SCHEMBL21281363 0.75 — —
SCHEMBL21281328 0.72 CYP19A1 (0.35) —
SCHEMBL19309922 0.71 AKR1B1 (0.33) —
SCHEMBL23470212 0.67 — —
SCHEMBL22199360 0.62 AKR1B1 (0.34) —
SCHEMBL23470170 0.62 DDB1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3214081-B1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF KANGPU BIOPHARMACEUTICALS LTD (CN) 2020-07-08 — — EP disclosed
EP-3214081-A1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Kangpu Biopharmaceuticals, Ltd. (CN) 2017-09-06 — — EP disclosed
Send feedback